The Beauty Health Company (NASDAQ:SKIN) Stock Rated “Hold” by Wall Street Analysts

Shares of The Beauty Health Company (NASDAQ:SKIN) have been assigned an average recommendation of “Hold” from the eight ratings firms that are presently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, six have given a hold recommendation and one has given a buy recommendation to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $18.00.

Several research analysts have recently weighed in on the company. Citigroup reissued a “hold” rating on shares of Beauty Health in a research report on Thursday, October 15th. TD Cowen assumed coverage on Beauty Health in a research note on Friday, October 30th. They issued a “hold” rating on the stock. Jefferies Financial Group reaffirmed a “hold” rating and set a $11.00 target price (up from $0.85) on shares of Beauty Health in a research note on Monday, October 19th. Zacks Research cut Beauty Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 20th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Beauty Health in a report on Wednesday, October 21st.

Beauty Health Stock Performance

NASDAQ:SKIN opened at $10.35 on Wednesday. The company has a market capitalization of $67.38 million, a PE ratio of -2.35 and a beta of 1.05. The company has a 50 day simple moving average of $12.37 and a two-hundred day simple moving average of $16.64. The company has a debt-to-equity ratio of 4.36, a quick ratio of 1.48 and a current ratio of 1.76. Beauty Health has a fifty-two week low of $9.68 and a fifty-two week high of $34.80.

Beauty Health (NASDAQ:SKIN) last issued its quarterly earnings results on Thursday, August 6th. The company reported ($0.40) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.50) by $0.10. Beauty Health had a negative net margin of 9.79% and a negative return on equity of 47.83%. The firm had revenue of $72.11 million for the quarter, compared to the consensus estimate of $74.45 million. Research analysts anticipate that Beauty Health will post -3.18 earnings per share for the current year.

Institutional Trading of Beauty Health

Several large investors have recently modified their holdings of SKIN. Bank of America Corp DE increased its stake in shares of Beauty Health by 19.2% in the 1st quarter. Bank of America Corp DE now owns 106,242 shares of the company’s stock valued at $95,000 after acquiring an additional 17,088 shares in the last quarter. Renaissance Technologies LLC lifted its position in shares of Beauty Health by 29.6% during the 1st quarter. Renaissance Technologies LLC now owns 283,791 shares of the company’s stock valued at $253,000 after acquiring an additional 64,900 shares during the period. Finally, Capricorn Fund Managers Ltd bought a new position in Beauty Health during the first quarter worth $17,270,000. Institutional investors and hedge funds own 93.26% of the company’s stock.

About Beauty Health

BeautyHealth is a global health and beauty company focused on providing technology, products and services for aesthetic and skincare businesses. Its flagship brand, HydraFacial, offers a non-invasive treatment platform that combines cleansing, exfoliation, extraction and hydration, with treatments delivered through proprietary devices and consumable solutions.

The company also provides professional skincare products, treatment systems and related solutions designed for use by physicians, dermatologists, aestheticians and other licensed practitioners.